Anxiety Disorders Completed Phase 2 Trials for Donepezil (DB00843)

Also known as: Anxiety Disorder / Anxiety NOS

IndicationStatusPhase
DBCOND0027904 (Anxiety Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01466270Study of Donepezil in Female Breast Cancer Survivors With Cognitive DysfunctionTreatment